Kynam Capital Management »

United Therapeutics Corporation shares owned by Kynam Capital Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 68k 296.06
2022-12-31 $28M 100k 278.09
2022-09-30 $32M 151k 209.38

More positions owned by Kynam Capital Management

Cogent Biosciences (COGT)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Beam Therapeutics (BEAM)
BioCryst Pharmaceuticals (BCRX)
Miragen Therapeutics (VRDN)
Tyra Biosciences (TYRA)
Cg Oncology (CGON)
Cytomx Therapeutics (CTMX)
Nurix Therapeutics (NRIX)
Wave Life Sciences SHS (WVE)
Cullinan Oncology (CGEM)
Immunocore Hldgs Ads (IMCR)

View all positions for Kynam Capital Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation